Rwanda launches national integrated malaria genomics surveillance platform On April 26, 2026, Rwanda launched a national integrated malaria genomics surveillance platform to strengthen its malaria control and elimination efforts. The initiative was unveiled by the Rwanda Biomedical Center (RBC) in Kigali, coinciding with World Malaria Day 2026, which carried the theme “Driven to End Malaria. Now we can. Now we must”. The platform aims to establish a routine, national malaria surveillance system that enables early detection and continuous monitoring of diagnostic and drug resistance markers. By generating high-quality genomic evidence, the system will inform government policies on malaria diagnostics, treatment, and control strategies. Developed with support from the Gates Foundation, the integrated platform represents a strategic advancement in Rwanda’s mission toward malaria elimination. It combines genomic data with existing surveillance systems to provide actionable insights for public health decision-making. The launch underscores Rwanda’s commitment to leveraging innovative, science-based approaches to combat malaria, a disease that remains a significant public health challenge across sub-Saharan Africa. Through real-time monitoring of parasite genetic changes, the platform will assist ensure that diagnostics and treatments remain effective as the pathogen evolves. This initiative builds on Rwanda’s strong track record in health innovation and positions the country as a regional leader in applying genomics to infectious disease control. By integrating cutting-edge technology into national health systems, Rwanda aims to accelerate progress toward a malaria-free future.
6